<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5009807 Figure_1-B</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Semi-quantitative PCR of miR-132 and negative control miRNAs in the hippocampus of antagomiR-132-injected mice (ant-132) in comparison to control-injected animals (aCSF and scramble) at six months of age. Sample size, n=9 per group.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_1-C</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. FISH of miR-132 and negative control miR-124 in the hippocampus of ant-132- and scramble-injected mice. Scramble probes were used as FISH negative controls. Scale bar, 500&#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_1-D</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Semi-quantitative PCR of miR-132 and miR-212 in the hippocampus of 3-month old miR-132 mimic-injected mice (miR-132) compared to animals injected with a negative control oligonucleotide (Ctr). Sample size, n=6 per group.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_2-A-B</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A. Amyloid staining (6E10) combined with miR-132 FISH in ant-132- and scramble-injected mice at six months of age. Scale bar, 500 &#956;m. B. Quantification of amyloid burden in hippocampus and cortex of ant-132-injected and control animals (see Materials and Methods). Sample size, n=4 per group.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_2-C-D</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D. ELISA of soluble (TBS) and insoluble (Formic acid) A&#946;40 and A&#946;42 levels in the hippocampus of ant-132- (C) and miR-132-injected (D) animals at six and three months of age, respectively. Sample size, n=6 per group.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_3-A-B</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of total TAU and pTAU (AT8, AT270) levels upon miR-132 knockdown (A) or overexpression (B) at six and three months of age, respectively. Sample size, n=9 per group (A) and n=6 per group (B). Values were normalized to the respective control groups and presented as mean &#177; SEM. Student's t-test was used.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_4-B</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Positive hits were validated by semi-quantitative qPCR in ant-132-injected mouse hippocampus. Black line indicates mean of scramble control set to 1. Dashed line indicates chosen threshold of 1.3-fold. Sample size, n=9 per group. Values were normalized to scramble-injected group and presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_5-A</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Luciferasereporter assay of wild-type (wt) and mutant (mut) ITPKB 3'UTR in HEK293 cells co-transfected with a synthetic miR-132 (miR-132) or a negative control (Neg Ctr) oligonucleotide.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_5-B</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. ELISA of A&#946;40 and A&#946;42 levels in HEK293-APPswecells transfected with a miR-132 antisense oligonucleotide (miR-132 inh), an siRNA against ITPKB (ITPKB siRNA) or both. The assays in A and B were performed in three independent experiments, each in triplicates.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_5-C</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Western blot analysis of ITPKB knock down in APPPS1 hippocampus using an siRNA oligonucleotide against ITPKB. Sample size, n=6 per group. Values were normalized to control-injected group (Ctr) and presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_5-D</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. ELISA of insoluble (Formic acid-soluble) A&#946;40 and A&#946;42 levels in the hippocampus of ITPKB siRNA- and control-injected animals at three months of age. Sample size, n=6 per group. Values were normalized to control group and presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_5-E-F</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F. Western blot analysis of ITPKB levels upon miR-132 down- (E) or up-regulation (F) at six and three months of age, respectively. Sample size, n=9 per group for miR-132 down regulation and n=6 per group for miR-132 overexpression. Values were normalized to control groups and presented as mean &#177; SEM.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_6-A</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of CTF&#946; (A) levels upon miR-132 down- (ant-132) (left panel) or upregulation (miR-132) (right panel) in APPPS1hippocampus at six and three months of age, respectively. Sample size, n=9 per group for miR-132 down regulation and n=6 per group for miR-132 overexpression. Values were normalized to respective control groups and presented as mean &#177; SEM. The Student's t-test was used.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_6-B</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of sAPP&#946;-swe (B) levels upon miR-132 down- (ant-132) (left panel) or upregulation (miR-132) (right panel) in APPPS1hippocampus at six and three months of age, respectively. Sample size, n=9 per group for miR-132 down regulation and n=6 per group for miR-132 overexpression. Values were normalized to respective control groups and presented as mean &#177; SEM. The Student's t-test was used.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_6-C</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of phosphorylated ERK1/2 (pERK1/2) (C) levels upon miR-132 down- (ant-132) (left panel) or upregulation (miR-132) (right panel) in APPPS1hippocampus at six and three months of age, respectively. Sample size, n=9 per group for miR-132 down regulation and n=6 per group for miR-132 overexpression. Values were normalized to respective control groups and presented as mean &#177; SEM. The Student's t-test was used.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_7-A</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Double immunofluorescence staining of amyloid plaques (6E10) and ITPKB in AD prefrontal cortex. Scale bar, 50 &#956;m. Arrowheads indicate ITPKB immunopositivity.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_7-B</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. miR-132 FISH coupled with double immunofluorescence against hyperphosphorylated TAU (AT8)-containing neurofibrillary tangles (NFTs) and ITPKB in AD prefrontal cortex. miR-124 was used as a control. Scale bar, 50 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_7-C</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Quantification of miR-132, ITPKB and hyperphosphorylated TAU (pTAU) signal in single neurons. Integrated intensity values of each signal per cell were normalized to the mean integrated density of each signal across all the cells analyzed (see Materials and Methods). Sample size (AD patients), n=3. Values are presented as mean &#177; SEM. Two-way Anova was used. Quantifications are summarized in the table provided. Arrow directions refer to the comparison of each normalized signal to the same signal in the other group (in the "low miR-132" group comparisons are made to the "high miR-132" group and vice versa).</text>
    </passage>
  </document>
  <document>
    <id>5009807 Figure_8-A</id>
    <infon key="sourcedata_document">2152</infon>
    <infon key="doi">10.15252/emmm.201606520</infon>
    <infon key="pmc_id">5009807</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>Semi-quantitative PCR of miR-132 and western blot analysis of ITPKB, phosphorylated (pERK1/2) and total ERK1/2, phosphorylated (AT8 , AT270) and total TAU, phosphorylated sphingosine kinase 1 (pSphK1), BACE1, full length APP (flAPP), APP CTFs and sAPP&#946; in human AD hippocampi (AD) compared to non demented control samples (ND). Sample size, n=39 for AD and n=15 for ND. Values were normalized to ND and presented as mean &#177; SEM. The Student's t-test was used.</text>
    </passage>
  </document>
</collection>
